Comparative Effects of TherapeuticU and Shockwave Therapy on Pain and QOL in Patients With Chronic Heel Spur Pain
Active, not recruitingNot applicableNCT06983457
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This research aims to compare the effectiveness of therapeutic ultrasound (TUS) and extracorporeal shockwave therapy (ESWT) in managing chronic heel spur pain and improving patients' quality of life. Chronic heel spur pain, often associated with plantar fasciitis, is a debilitating condition that affects mobility and daily activities.
Study details
- Official title
- Comparative Effects of Therapeutics Ultrasound and Shockwave Therapy on Pain and Quality of Life in Patients With Chronic Heel Spur Pain. A Randomized Controlled Clinical Trial
- Conditions
- Heel Spur
- Interventions
- Combination product: Therapeutic ultrasound
- Combination product: Shockwave Therapy
- Sponsor
- Superior University
- Start date
- 2025-03-20
- Primary completion
- 2025-06-20
- Sex
- All
- Age range
- from 30 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Pakistan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients diagnosed with chronic heel spur pain, confirmed through imaging studies (e.g., X-ray, ultrasound). * Age range: 30-60 years. Both male and female included * Chronic heel pain persisting for more than 1 month. * Individuals with no prior surgical intervention for heel pain. * Ability to provide informed consent and comply with the treatment protocol. Exclusion Criteria: * Presence of systemic inflammatory conditions such as rheumatoid arthritis or gout. * History of previous steroid injection less than 6 weeks. * prior NSAID treatment less than 1 week, * Individuals with contraindications to ultrasound or shockwave therapy, such as pacemakers or implanted devices.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06983457